top of page

Phone:  +918866862020

  • Whatsapp
  • Instagram
  • Facebook
  • X
  • LinkedIn

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Enhertu 100mg Injection

Enhertu 100mg Injection

Manufacturer/Marketed By : ASTRAZENECA PHARMA INDIA LTD

$1779.03 $1464.16

Enhertu 100mg Injection contains the active ingredient Trastuzumab deruxtecan, a targeted therapy used to treat certain types of breast and stomach cancers. Enhertu 100 mg uses in adult patients with...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

TRASTUZUMAB DERUXTECAN

Active Pharmaceutical Ingredient

Enhertu 100mg Injection

SKU ASTRAZENECA PHARMA INDIA LTD
السعر الأصلي

1,779.03$

سعر البيع

1,464.16$

Enhertu 100mg Injection contains the active ingredient Trastuzumab deruxtecan, a targeted therapy used to treat certain types of breast and stomach cancers. Enhertu 100 mg uses in adult patients with Enhertu for HER2-positive breast cancer or HER2-positive gastric cancer. This medicine is not recommended for individuals under 18 years of age. The Enhertu dosing infusion every 3 weeks is the standard schedule, meaning patients typically receive the medicine once every three weeks under the supervision of a healthcare professional. Enhertu works by binding to HER2-positive cancer cells and delivering a cytotoxic agent directly into them, which helps destroy the cancer cells while minimizing damage to surrounding healthy tissues. The standard Enhertu dosing involves an infusion every 3 weeks, administered by a healthcare professional in a clinical setting. Patients and doctors often compare Enhertu vs Kadcyla to determine the most suitable HER2-targeted treatment, as both are used for HER2-positive breast cancer but differ in formulation, mechanism, and clinical outcomes. Like all medicines, Enhertu may cause side effects. Common Enhertu infusion adverse reactions can include nausea, vomiting, fatigue, decreased appetite, and infusion-related reactions. More serious side effects may involve lung or heart problems, so regular monitoring is important. Enhertu cost In India, the Enhertu Injection price can vary depending on location and supplier. The Enhertu 100 mg price in India and the Enhertu price per month may be high, making it important for patients to discuss financial assistance programs with their doctor or pharmacist. Enhertu injection uses include the treatment of HER2-positive metastatic breast cancer in patients who have already received other anti-HER2 therapies, as well as HER2-positive advanced gastric cancer in patients previously treated with a trastuzumab-based regimen. Enhertu 100mg Injection Price Varies by retailer and location. You can Buy Enhertu 100mg Injection online at MrMed For Affordable Prices.

Active Pharmaceutical Ingredient

TRASTUZUMAB DERUXTECAN

Uses

• Treats HER2-positive breast cancer that is metastatic or unresectable for patients who have had prior anti-HER2 treatments.
• Effective for HER2-low metastatic breast cancer after prior chemotherapy.
• Treats HER2-mutated non-small cell lung cancer (NSCLC) that is metastatic or unresectable following prior treatment.
• Used for HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma after prior trastuzumab-based therapy.
• For HER2-positive (IHC 3+) metastatic solid tumours when no other satisfactory treatments are available.

Benefits

Enhertu 100mg Injection is used in the treatment of certain types of breast and gastric cancers that express specific proteins. It works as a targeted therapy by delivering a potent anti-cancer agent directly to cancer cells, helping to destroy them while limiting damage to healthy cells. By targeting cancer more precisely, it helps slow down disease progression and may reduce tumor size. This medicine can also help relieve symptoms associated with cancer, supporting better overall health. Regular use as prescribed improves treatment response and enhances quality of life.

Side Effects

Enhertu 100mg Injection Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Most Common Side Effects

• Nausea (feeling sick), vomiting
• Tiredness
• Decreased appetite
• Blood tests showing decreased red or white blood cells or platelets
• Hair loss
• Diarrhoea
• Constipation
• Blood tests showing increased levels of the liver enzymes such as transaminases
• Pain in muscles and bones
• Weight loss
• Fever
• Abdominal (belly) pain
• Infections of the nose and throat, including flu-like symptoms
• Headache
• Blisters in or around your mouth
• Cough
• Blood tests showing low blood potassium levels
• Indigestion
• Breathing difficulties
• Swelling of ankles and feet
• Nosebleed
• Altered/bad taste in the mouth
• Infection of the lungs

Common Side Effects

• Severe allergic reactions (rashes, itching, difficulty in breathing, fever)

How To Use

Enhertu 100mg Injection is administered through an intravenous (IV) infusion by a healthcare provider every three weeks. Before each treatment, you may receive medication to prevent nausea and vomiting. If you have an infusion-related reaction, the infusion may be slowed, paused, or permanently stopped for severe reactions. If you miss a dose, it's important to contact your healthcare provider immediately to reschedule. The number of treatments will depend on your healthcare provider's assessment. Your healthcare Provider will decide the Enhertu 100mg dosage and administration.

Safety Advice

• Breast Feeding: Enhertu 100mg Injection in nursing mothers has not been studied, and whether it is excreted in breast milk is unknown. Hence, it is not recommended to take this medication in breastfeeding mothers.
• Alcohol: Enhertu 100mg Injection is not known to interact with alcohol. However, both Enhertu 100 mg Injection and alcohol can have similar side effects, such as headaches and nausea. Be vigilant about these side effects and contact your doctor for more advice.
• Liver: Before beginning treatment with Enhertu 100mg Injection, it is important to let your doctor know if you suffer from liver impairment, as this may necessitate an adjustment in dosage depending on the severity of your liver condition.
• Lungs: If you have a history of lung disease, you may be at a higher risk of developing interstitial lung disease when using Enhertu 100mg Injection. Therefore, informing your doctor about any lung issues you have before beginning treatment with this medication is important.
• Driving: Enhertu 100mg Injection does not impair your ability to drive or operate machinery. However, be cautious if you feel dizzy, tired, or have a headache. Contact your doctor for more advice.
• Pregnancy: Enhertu 100mg Injection, when taken during pregnancy, can cause neonatal complications. Hence, it is not recommended to take this medication if you are pregnant, planning for pregnancy or think you may become pregnant.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page